Bin Mahmood Syed Usman, Mori Makoto, Yousef Sameh, Mullan Clancy W, Mangi Abeel A, Geirsson Arnar
Department of Surgery, Section of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, USA.
Interact Cardiovasc Thorac Surg. 2020 Feb 1;30(2):243-248. doi: 10.1093/icvts/ivz259.
Evidence of an association between postoperative survival and the presenting syndrome following coronary artery bypass grafting (CABG) is limited. Our goal was to evaluate whether the presenting symptoms of acute coronary syndrome (ACS) or stable ischaemic heart disease were associated with mid-term survival in patients undergoing CABG.
We performed a single-centre retrospective study involving consecutive CABG operations from 2011 to 2016. Post-discharge survival was ascertained via patient-level data linkage with the State of Connecticut vital statistics. Baseline and postoperative variables were compared between the two groups. The multivariate Cox proportional hazard model, adjusted for demographics and comorbidity, was used to show whether the presenting syndrome category was independently associated with mid-term survival.
A total of 1631 patients were included: 794 with stable ischaemic heart disease and 837 with ACS. Patients with ACS who underwent CABG showed more comorbidities. The overall 30-day mortality rate was 1.8% (ACS 2.3% vs stable ischaemic heart disease 1.3%; P = 0.12). In-hospital, postoperative outcomes revealed higher rates of prolonged ventilation (11.7% vs 4.8%; P < 0.001), pneumonia (6.6% vs 3.9%; P = 0.016) and stay in the intensive care unit (3.7 ± 4.0 vs 3.2 ± 2.7 days; P = 0.014) in patients with ACS. The overall mean duration of the long-term follow-up period was 27.9 ± 16.5 months, during which 117 deaths occurred. The multivariable Cox proportional hazard model adjusted for demographics and comorbidity showed that ACS was not a predictor of mid-term mortality [hazard ratio (HR) 1.26, 95% confidence interval (CI) 0.84-1.90; P = 0.26]. Other significant predictors were cardiogenic shock (HR 2.12, 95% CI 1.04-4.33; P = 0.039) and history of congestive heart failure (HR 1.78, 95% CI 1.18-2.69; P = 0.0062).
The presenting syndrome was not an independent predictor of the mid-term mortality rate. The results indicate that the classification of the presenting syndrome may be fluid and that clinical decision-making for postoperative care of patients who have CABG directed by category of presenting syndrome needs careful consideration. These data should be interpreted in the context of the limitations of this study.
冠状动脉旁路移植术(CABG)后术后生存率与就诊综合征之间关联的证据有限。我们的目标是评估急性冠状动脉综合征(ACS)或稳定型缺血性心脏病的就诊症状是否与接受CABG患者的中期生存率相关。
我们进行了一项单中心回顾性研究,纳入了2011年至2016年连续进行的CABG手术。通过将患者层面的数据与康涅狄格州生命统计数据进行关联来确定出院后的生存率。比较两组之间的基线和术后变量。使用针对人口统计学和合并症进行调整的多变量Cox比例风险模型来显示就诊综合征类别是否与中期生存率独立相关。
共纳入1631例患者:794例患有稳定型缺血性心脏病,837例患有ACS。接受CABG的ACS患者合并症更多。总体30天死亡率为1.8%(ACS为2.3%,稳定型缺血性心脏病为1.3%;P = 0.12)。在住院期间,术后结果显示ACS患者的长时间通气率更高(11.7%对4.8%;P < 0.001)、肺炎发生率更高(6.6%对3.9%;P = 0.016)以及在重症监护病房的停留时间更长(3.7 ± 4.0天对3.2 ± 2.7天;P = 0.014)。长期随访期的总体平均持续时间为27.9 ± 16.5个月,在此期间发生了117例死亡。针对人口统计学和合并症进行调整的多变量Cox比例风险模型显示,ACS不是中期死亡率的预测因素[风险比(HR)1.26,95%置信区间(CI)0.84 - 1.90;P = 0.26]。其他显著的预测因素是心源性休克(HR 2.12,95% CI 1.04 - 4.33;P = 0.039)和充血性心力衰竭病史(HR 1.78,95% CI 1.18 - 2.69;P = 0.0062)。
就诊综合征不是中期死亡率的独立预测因素。结果表明就诊综合征的分类可能具有不确定性,并且根据就诊综合征类别指导CABG患者术后护理的临床决策需要仔细考虑。这些数据应结合本研究的局限性来解读。